Jones Financial Companies Lllp Purchases 429,265 Shares of Dolby Laboratories $DLB

Key Points

• Jones Financial Companies Lllp significantly increased its stake in Dolby Laboratories by 241,160.1%, now owning 429,443 shares valued at $36,975,000.
• Dolby Laboratories recently declared a quarterly dividend of $0.33 per share, representing an annualized yield of 1.8% with a payout ratio of 48.35%.
• Wall Street analysts have recently upgraded Dolby Laboratories' rating to "buy", with the average target price set at $95.75.

Jones Financial Companies Lllp grew its stake in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 241,160.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 429,443 shares of the electronics maker's stock after buying an additional 429,265 shares during the quarter. Jones Financial Companies Lllp owned approximately 0.45% of Dolby Laboratories worth $36,975,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Securian Asset Management Inc. raised its position in shares of Dolby Laboratories by 3.0% during the first quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker's stock worth $373,000 after acquiring an additional 137 shares during the last quarter. MAI Capital Management grew its stake in Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after purchasing an additional 162 shares during the period. Net Worth Advisory Group grew its stake in Dolby Laboratories by 5.2% during the first quarter. Net Worth Advisory Group now owns 3,591 shares of the electronics maker's stock worth $288,000 after purchasing an additional 178 shares during the period. US Bancorp DE grew its stake in Dolby Laboratories by 18.6% during the first quarter. US Bancorp DE now owns 1,444 shares of the electronics maker's stock worth $116,000 after purchasing an additional 226 shares during the period. Finally, Linden Thomas Advisory Services LLC grew its stake in Dolby Laboratories by 2.7% during the first quarter. Linden Thomas Advisory Services LLC now owns 8,635 shares of the electronics maker's stock worth $693,000 after purchasing an additional 229 shares during the period. Institutional investors own 58.56% of the company's stock.

Analyst Upgrades and Downgrades

DLB has been the subject of several recent analyst reports. Tigress Financial raised their target price on Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. Baird R W raised Dolby Laboratories to a "hold" rating in a research note on Friday, September 5th. Robert W. Baird initiated coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a "neutral" rating and a $74.00 target price for the company. Wall Street Zen upgraded shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Finally, Rosenblatt Securities restated a "buy" rating and issued a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $95.75.

Dolby Laboratories Trading Down 1.8%

Dolby Laboratories stock traded down $1.28 during trading on Wednesday, hitting $71.01. 389,146 shares of the company were exchanged, compared to its average volume of 440,906. The business's 50 day moving average is $73.88 and its 200 day moving average is $75.66. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66. The company has a market capitalization of $6.81 billion, a P/E ratio of 26.01 and a beta of 0.93.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. During the same quarter in the prior year, the company posted $0.71 earnings per share. Dolby Laboratories's revenue was up 9.2% compared to the same quarter last year. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Equities analysts expect that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 annualized dividend and a yield of 1.9%. Dolby Laboratories's payout ratio is currently 48.35%.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 39,875 shares of the business's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $74.82, for a total value of $2,983,447.50. Following the transaction, the chief executive officer owned 114,725 shares of the company's stock, valued at approximately $8,583,724.50. The trade was a 25.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Shriram Revankar sold 7,000 shares of the business's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. This represents a 9.04% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 99,366 shares of company stock worth $7,352,963. Insiders own 38.39% of the company's stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.